Toripalimab Uses, Dosage, Side Effects and more
Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).
Trade Name | Toripalimab |
Generic | Toripalimab |
Toripalimab Other Names | Toripalimab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |